litlas
Log inCreate account

Jean Davignon

Active 1968–2014

66
Papers
18,500
Citations
66
h-index
66
i10-index

Citations

Citations per year for Jean Davignon1955: 1 citations1968: 1 citations1969: 3 citations1970: 4 citations1971: 5 citations1972: 8 citations1973: 4 citations1974: 3 citations1975: 6 citations1976: 5 citations1977: 4 citations1978: 4 citations1979: 3 citations1980: 6 citations1981: 6 citations1982: 4 citations1983: 4 citations1984: 6 citations1985: 3 citations1986: 9 citations1987: 17 citations1988: 24 citations1989: 28 citations1990: 27 citations1991: 38 citations1992: 46 citations1993: 48 citations1994: 72 citations1995: 86 citations1996: 74 citations1997: 76 citations1998: 88 citations1999: 119 citations2000: 136 citations2001: 139 citations2002: 141 citations2003: 85 citations2004: 127 citations2005: 111 citations2006: 129 citations2007: 123 citations2008: 143 citations2009: 130 citations2010: 138 citations2011: 151 citations2012: 134 citations2013: 116 citations2014: 137 citations2015: 126 citations2016: 138 citations2017: 133 citations2018: 109 citations2019: 303 citations2020: 307 citations2021: 298 citations2022: 246 citations2023: 152 citations2024: 205 citations2025: 92 citations2026: 2 citations1956–1967: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,823 citing papers, 28.1% of this breakdownCanada: 461 citing papers, 7.1% of this breakdownUnited Kingdom: 396 citing papers, 6.1% of this breakdownChina: 393 citing papers, 6% of this breakdownItaly: 337 citing papers, 5.2% of this breakdownGermany: 253 citing papers, 3.9% of this breakdownNetherlands: 242 citing papers, 3.7% of this breakdownFrance: 237 citing papers, 3.6% of this breakdownAustralia: 218 citing papers, 3.4% of this breakdownJapan: 184 citing papers, 2.8% of this breakdownSpain: 149 citing papers, 2.3% of this breakdownSweden: 127 citing papers, 2% of this breakdown
0%28.1%Other 25.8%

Institutions

Fields

  • Medicine74.7%
  • Biochemistry, Genetics and Molecular Biology14.2%
  • Immunology and Microbiology3.1%
  • Nursing2.2%
  • Neuroscience1.6%
  • Agricultural and Biological Sciences0.9%
  • Other3.3%

Topics

  • Lipoproteins and Cardiovascular Health11.6%
  • Diabetes, Cardiovascular Risks, and Lipoproteins5.7%
  • Alzheimer's disease research and treatments3.8%
  • Cholesterol and Lipid Metabolism3%
  • Cancer, Lipids, and Metabolism2.9%
  • Atherosclerosis and Cardiovascular Diseases2.7%
  • Other70.3%

Coauthors

All papers

Open in search
  1. Role of Endothelial Dysfunction in Atherosclerosis

    Authors: Jean Davignon, Peter Ganz - Circulation 2004 cited by 2,499

  2. Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis

    Authors: Steven E. Nissen, Stephen J. Nicholls, İlke Sipahi, Peter Libby, Joel S. Raichlen, Christie M. Ballantyne, Jean Davignon, Raimund Erbel, Jean Charles Fruchart, Jean‐Claude Tardif, Paul Schoenhagen, Tim Crowe, Valerie A. Cain, Kathy Wolski, Marlene Goormastic, E. Murat Tuzcu, for the ASTEROID Investigators - JAMA 2006 cited by 2,037

  3. Beneficial Cardiovascular Pleiotropic Effects of Statins

    Authors: Jean Davignon - Circulation 2004 cited by 945

  4. Proprotein convertase subtilisin/kexin type 9 (PCSK9)

    Authors: Ahmed Zaid, Anna Roubtsova, Rachid Essalmani, Jadwiga Marcinkiewicz, Ann Chamberland, Josée Hamelin, Michel J. Tremblay, Hélène Jacques, Weijun Jin, Jean Davignon, Nabil G. Seidah, Annik Prat - Hepatology 2008 cited by 400

  5. Statins Upregulate PCSK9 , the Gene Encoding the Proprotein Convertase Neural Apoptosis-Regulated Convertase-1 Implicated in Familial Hypercholesterolemia

    Authors: Geneviève Dubuc, Ann Chamberland, Hanny Wassef, Jean Davignon, Nabil G. Seidah, Lise Bernier, Annik Prat - Arteriosclerosis Thrombosis and Vascular Biology 2004 cited by 605

  6. Potential Mechanisms Leading to the Abnormal Lipid Profile in Patients With Rheumatoid Arthritis Versus Healthy Volunteers and Reversal by Tofacitinib

    Authors: Christina Charles‐Schoeman, Roy Fleischmann, Jean Davignon, Howard J. Schwartz, Scott Turner, Carine Beysen, Mark A. Milad, Marc K. Hellerstein, Zhen Luo, Irina V Kaplan, Richard J. Riese, Andrea Zuckerman, Iain B. McInnes - Arthritis & Rheumatology 2014 cited by 185

  7. Apolipoprotein E polymorphism and atherosclerosis.

    Authors: Jean Davignon, Richard E. Gregg, Charles F. Sing - Arteriosclerosis An Official Journal of the American Heart Association Inc 1988 cited by 1,985

  8. The antioxidant effects of statins

    Authors: Jean Davignon, Robert F. Jacob, Ronald P. Mason - Coronary Artery Disease 2004 cited by 163

  9. Annexin A2 Is a Natural Extrahepatic Inhibitor of the PCSK9-Induced LDL Receptor Degradation

    Authors: Nabil G. Seidah, Steve Poirier, Maxime Denis, Rex A. Parker, Bowman Miao, Claudio Mapelli, Annik Prat, Hanny Wassef, Jean Davignon, Katherine A. Hajjar, Gaétan Mayer - PLoS ONE 2012 cited by 124

  10. Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis.

    Authors: Jean Dallongeville, Suzanne Lussier‐Cacan, Jean Davignon - Journal of Lipid Research 1992 cited by 451

  11. Oxidative Insults Are Associated with Apolipoprotein E Genotype in Alzheimer's Disease Brain

    Authors: Charles Ramassamy, Diana A. Averill‐Bates, Uwe Beffert, Louise Théroux, Suzanne Lussier‐Cacan, Jeffrey S. Cohn, Yves Christen, Alain René Schoofs, Jean Davignon, Judes Poirier - Neurobiology of Disease 2000 cited by 193

  12. Current and future treatment of hyperlipidemia: the role of statins

    Authors: Michel Farnier, Jean Davignon - The American Journal of Cardiology 1998 cited by 193

  13. Apolipoprotein E and atherosclerosis: insight from animal and human studies

    Authors: Jean Davignon, Jeffrey S. Cohn, Laurence Mabile, Lise Bernier - Clinica Chimica Acta 1999 cited by 210

  14. The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans.

    Authors: Daniel J. Rader, W. Alexander Mann, William J. Cain, H.G. Kraft, David Usher, Loren A. Zech, J M Hoeg, Jean Davignon, P J Lupien, Mariann Grossman - Journal of Clinical Investigation 1995 cited by 206

  15. Rate of Production of Plasma and Very-Low-Density Lipoprotein (VLDL) Apolipoprotein C-III Is Strongly Related to the Concentration and Level of Production of VLDL Triglyceride in Male Subjects with Different Body Weights and Levels of Insulin Sensitivity

    Authors: Jeffrey S. Cohn, Bruce W. Patterson, Kris D. Uffelman, Jean Davignon, George Steiner - The Journal of Clinical Endocrinology & Metabolism 2004 cited by 172

  16. Effect of Statin Withdrawal on Frequency of Cardiac Events After Vascular Surgery

    Authors: Olaf Schouten, Sanne E. Hoeks, G.M. Welten, Jean Davignon, John J.P. Kastelein, Radosav Vidaković, Harm H.H. Feringa, Martin Dunkelgrün, Ron T. van Domburg, Jeroen J. Bax, Don Poldermans - The American Journal of Cardiology 2007 cited by 167

  17. Apolipoprotein E and β-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent

    Authors: Uwe Beffert, Jeffrey S. Cohn, Caroline Petit-Turcotte, Michel Tremblay, Nicole Aumont, Charles Ramassamy, Jean Davignon, Judes Poirier - Brain Research 1999 cited by 146

  18. PCSK9 R46L, Lower LDL, and Cardiovascular Disease Risk in Familial Hypercholesterolemia

    Authors: Yascara Grisel Luna Saavedra, Robert Dufour, Jean Davignon, Alexis Baass - Arteriosclerosis Thrombosis and Vascular Biology 2014 cited by 76

  19. A new method for measurement of total plasma PCSK9: clinical applications

    Authors: Geneviève Dubuc, Michel J. Tremblay, Guillaume Paré, Hélène Jacques, Josée Hamelin, Suzanne Benjannet, Lucie Boulet, Jacques Genest, Lise Bernier, Nabil G. Seidah, Jean Davignon - Journal of Lipid Research 2009 cited by 221

  20. Plasma PCSK9 Is Associated with Age, Sex, and Multiple Metabolic Markers in a Population-Based Sample of Children and Adolescents

    Authors: Alexis Baass, Geneviève Dubuc, Michel J. Tremblay, Edgard Delvin, Jennifer O’Loughlin, Émile Lévy, Jean Davignon, Marie Lambert - Clinical Chemistry 2009 cited by 207

  21. Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease

    Authors: Martin R. Farlow, Debomoy K. Lahiri, Judes Poirier, Jean Davignon, L. Schneider, Siu L. Hui - Neurology 1998 cited by 200

  22. The role of potatoes and potato components in cardiometabolic health: A review

    Authors: Carla McGill, Anne C. Kurilich, Jean Davignon - Annals of Medicine 2013 cited by 176

  23. Novel Loss-of-Function PCSK9 Variant Is Associated with Low Plasma LDL Cholesterol in a French-Canadian Family and with Impaired Processing and Secretion in Cell Culture

    Authors: Janice Mayne, Thilina Dewpura, Angela Raymond, Lise Bernier, Marion Cousins, Teik Chye Ooi, Jean Davignon, Nabil G. Seidah, Majambu Mbikay, Michel Chrétien - Clinical Chemistry 2011 cited by 109

  24. Apolipoprotein E and Atherosclerosis

    Authors: Jean Davignon - Arteriosclerosis Thrombosis and Vascular Biology 2005 cited by 98